1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KLHL23 CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA DOCK8 CTRPv2 pan-cancer AAC 0.23 6e-07
mRNA BCL2 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA ZNF616 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA PCYT1B CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA MRPS18B CTRPv2 pan-cancer AAC -0.17 6e-07
mRNA XKR7 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA SNN CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA TYROBP CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA ELAVL4 CTRPv2 pan-cancer AAC 0.25 6e-07
Download CSV